福森药业(01652.HK)：余浩铭获委任为独立非执行董事

Core Viewpoint - Fosun Pharma (01652.HK) announced significant changes in its board of directors and audit committee effective September 30, 2025 [1] Group 1 - Shi Yongjin has resigned as an independent non-executive director and will no longer serve as the chairman of the audit committee [1] - Yu Haoming has been appointed as an independent non-executive director and a member of the audit committee [1] - Li Guodong has been appointed as the chairman of the audit committee [1]